Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized
AssigneeRegenerx Biopharmaceuticals, Inc.
InventorsDavid CROCKFORD, Allan L. GOLDSTEIN
Life of this patent
Estimating the term…
Abstract
A composition including a peptide agent including amino acid sequence LKKTET [SEQ ID NO: 1] or LKKTNT [SEQ ID NO: 2], a conservative variant thereof, or a stimulating agent that stimulates production of an LKKTET [SEQ ID NO: 1] or LKKTNT [SEQ ID NO: 2] peptide, or a conservative variant thereof, the composition including at least one amino acid stabilizing agent or lyophilization bulking agent, the composition being in lyophilized form, or in a form capable of being lyophilized.
Claims15
A method of treating dry eye syndrome in a subject, comprising administering to the subject an ophthalmically acceptable composition having a pH of about 6.8-8.1 and comprising a peptide agent comprising amino acid sequence LKKTET or Thymosin β4 (Tβ4).
Dependencies are inferred from the claim text.